Vanguard Group Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,384,592 shares of RVPH stock, worth $2.66 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,384,592
Previous 1,025,249
35.05%
Holding current value
$2.66 Million
Previous $1.48 Million
62.26%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RVPH
# of Institutions
46Shares Held
10.4MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$6.12 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$3.52 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$2.91 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$1.31 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT512KShares$983,4270.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $39.3M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...